Advanced Detection Method for Dengue NS1 Protein Using Ultrasensitive ELISA with Thio-NAD Cycling

Viruses. 2023 Sep 8;15(9):1894. doi: 10.3390/v15091894.

Abstract

Dengue fever, a mosquito-borne disease in tropical and subtropical climates caused by the dengue virus (DENV), has become a major social and economic burden in recent years. However, current primary detection methods are inadequate for early diagnosis of DENV because they are either time-consuming, expensive, or require training. Non-structural protein 1 (NS1) is secreted during DENV infection and is thus considered a suitable biomarker for the development of an early detection method. In the present study, we developed a detection method for the NS1 protein based on a previously reported thio-NAD cycling ELISA (i.e., ultrasensitive ELISA) and successfully achieved a LOD of 1.152 pg/mL. The clinical diagnosis potential of the detection system was also evaluated by using 85 patient specimens, inclusive of 60 DENV-positive and 25 DENV-negative specimens confirmed by the NAAT method. The results revealed 98.3% (59/60) sensitivity and 100% (25/25) specificity, which was in almost perfect agreement with the NAAT data with a kappa coefficient of 0.972. The present study demonstrates the diagnostic potential of using an ultrasensitive ELISA as a low-cost, easy-to-use method for the detection of DENV compared with NAAT and could be of great benefit in low-income countries.

Keywords: NS1 protein; dengue virus; detection; nucleic acid application test; ultrasensitive ELISA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biological Transport
  • Dengue* / diagnosis
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • NAD*

Substances

  • thionicotinamide adenine dinucleotide
  • NAD

Grants and funding

This research was funded by the Japan Society for the Promotion of Science KAKENHI, 20H04556, to E.I., the Waseda University Grant for Special Research Projects, 2023Q-004, to E.I., by SPRING from the Japan Science and Technology Agency, JPMJSP2128, to P.K.C., and the National Health Research Institute, Taiwan, NHRI-110A1-MRCO-03212101, to J.J.T.